Challenges Facing the Future of Cholangiocarcinoma

Jesper Andersen, PhD
Published Online: Friday, May 19, 2017

Jesper Andersen, PhD, associate professor, Biotech and Innovation Centre, University of Copenhagen, discusses the challenges facing the future treatment of patients with cholangiocarcinoma.

It is difficult to do genomic stratification in this disease, as incidence is still relatively rare. Additionally, Andersen adds, it is difficult to access to good quality tissue from patients that have gone through clinical trials or genetic studies.

Jesper Andersen, PhD, associate professor, Biotech and Innovation Centre, University of Copenhagen, discusses the challenges facing the future treatment of patients with cholangiocarcinoma.

It is difficult to do genomic stratification in this disease, as incidence is still relatively rare. Additionally, Andersen adds, it is difficult to access to good quality tissue from patients that have gone through clinical trials or genetic studies.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: Optimizing Treatment and Management of Soft Tissue Sarcoma in Community OncologyNov 30, 20171.5
Clinical Vignette Series: 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®Feb 28, 20182.0
Publication Bottom Border
Border Publication